These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6133644)

  • 21. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
    Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
    J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockade after myocardial infarction.
    Drug Ther Bull; 1977 Apr; 15(9):33-4. PubMed ID: 17532
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of beta-adrenoblockaders during and after an acute myocardial infarct].
    Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa; Buravlev MB
    Ter Arkh; 1994; 66(8):84-8. PubMed ID: 7985167
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beta blockade in acute myocardial infarction].
    Nitter-Hauge S
    Tidsskr Nor Laegeforen; 1987 Oct; 107(28):2431-2. PubMed ID: 2891208
    [No Abstract]   [Full Text] [Related]  

  • 27. From the NIH: Implications of the recent beta-blocker clinical trials for patients after myocardial infarction.
    JAMA; 1983 May; 249(18):2482-3. PubMed ID: 6133013
    [No Abstract]   [Full Text] [Related]  

  • 28. The anturane reinfarction trial.
    Rothlin M
    N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6103510
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta Blockade after myocardial infarction. Absence of evidence is failure of research policy.
    Lipman T
    BMJ; 2000 Feb; 320(7234):581. PubMed ID: 10744406
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adrenergic beta receptor blockaders as a secondary prevention after acute myocardial infarction].
    Jensen G; Sigurd B
    Ugeskr Laeger; 1981 Nov; 143(48):3241-5. PubMed ID: 6120594
    [No Abstract]   [Full Text] [Related]  

  • 33. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings of the Workshop on Implications of Recent Beta-blocker Trials for Post-Myocardial Infarction Patients. May 25-26, 1982, National Institutes of Health, Bethesda, Maryland.
    Circulation; 1983 Jun; 67(6 Pt 2):I1-111. PubMed ID: 6133638
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-blockers in the prevention of myocardial infarction.
    Hampton JR
    Practitioner; 1984 Jan; 228(1387):55-63. PubMed ID: 6141556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blockers post-MI: an example of age discrimination?
    Gottlieb S
    Postgrad Med; 2002 Dec; 112(6 Suppl Heart):28-33. PubMed ID: 19667615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of inpatient initiation of beta-blockers.
    Ventura HO
    Am Heart J; 2004 Dec; 148(6):944-50. PubMed ID: 15632876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunction.
    Fonarow GC; Abraham WT; Cannon CP; Gheorghiade M; Sackner-Bernstein JD; Udelson JE;
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S54-9. PubMed ID: 14584479
    [No Abstract]   [Full Text] [Related]  

  • 40. Practical considerations of beta-blockade in the management of the post-myocardial infarction patient.
    Fonarow GC
    Am Heart J; 2005 Jun; 149(6):984-93. PubMed ID: 15976779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.